Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction

Paion AG

www.paion.de

Latest From Paion AG

Bookmark
  • Interviews

BIO-Europe Spring 2019: Finally, Paion Teeters On Cusp Of Commercialization

By Mike Ward

Wolfgang Söhngen, CEO and founder of Paion, discusses the company’s anesthetic/sedative, remimazolam, which has been filed for approval in China, Japan and the US, as well as broader business strategies.

Commercial Business Strategies
Bookmark
  • News

Pipeline Watch: Top-line Phase III Results For KX2-391, Dasotraline And Brigatinib

By John Davis

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals
Bookmark
  • News

Pipeline Watch: Patisiran, Etrolizumab, ALKS8700 Phase III Readouts

By John Davis

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
Bookmark
  • News

Pipeline Watch: Phase III Starts In PTSD, Alzheimer’s Disease And Pancreatic Cancer

By John Davis

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Paion GMBH
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Paion AG
  • Senior Management
  • Wolfgang Sohngen, MD, PhD, CEO
    Abdelghani Omari, CFO
    Mariola Sohngen, MD, PhD, CMO
    Jürgen Raths, MD, COO
  • Contact Info
  • Paion AG
    Phone: (49) 241 4453 0
    Martinstrasse 10-12
    Aachen, 52062
    Germany
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By